Quick Answer
Nuo Therapeutics, Inc. reported Net Income of -$2.51 million for fiscal year 2025.
Nuo Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$2.51M | -8.1% |
| 2024 | -$2.32M | +26.7% |
| 2023 | -$3.17M | +0.0% |
| 2022 | -$3.17M | -3398.1% |
| 2021 | -$90.7K | +0.2% |
| 2020 | -$90.9K | +92.4% |
| 2019 | -$1.19M | +22.5% |
| 2018 | -$1.54M | +89.7% |
| 2017 | -$14.98M | +71.6% |
| 2015 | -$52.81M | -179.7% |
| 2014 | -$18.88M | +6.7% |
| 2013 | -$20.25M | -2.3% |
| 2012 | -$19.80M | -464.0% |
| 2011 | -$3.51M | +48.5% |
| 2010 | -$6.82M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$537.9K | +7.0% | +17.2% |
| June 30, 2025 | -$649.7K | -20.3% | +12.9% |
| March 31, 2025 | -$746.1K | -5.3% | -29.1% |
| September 30, 2024 | -$578.2K | +26.9% | -7.0% |
| June 30, 2024 | -$540.1K | +38.1% | +23.8% |
| March 31, 2024 | -$708.8K | +17.2% | +10.4% |
| September 30, 2023 | -$790.6K | +13.4% | +9.3% |
| June 30, 2023 | -$871.9K | +5.6% | -1.9% |
- Nuo Therapeutics, Inc. showed a decrease of -8.1% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, Nuo Therapeutics, Inc.’s net income has grown by 63.1% (from -$6.82 million to -$2.51 million).
- The most recent figure is from Nuo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: